Shui O. Leung
Hong Kong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
SM03, a non-depleting anti-CD22 antibody, modulates B cell activation and immune crosstalk to attenuate autoimmunity.
Journal: Journal of translational autoimmunity
Published: March 19, 2026
Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model.
Journal: The Journal of investigative dermatology
Published: October 20, 2025
Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model.
Journal: The Journal of investigative dermatology
Published: October 20, 2025
SM17, an anti-interleukin-17 receptor B antibody, ameliorates pathogenesis of chronic rhinosinusitis with nasal polyps and idiopathic pulmonary fibrosis via Th2/Th17 dual modulation.
Journal: ERJ open research
Published: August 08, 2025
CD22 modulation alleviates amyloid β-induced neuroinflammation.
Journal: Journal of neuroinflammation
Published: November 13, 2024
Discovery of a new anti-γc antibody in clinical development for the treatment of autoimmune diseases.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 11, 2024
Suppression of NK Cell Activation by JAK3 Inhibition: Implication in the Treatment of Autoimmune Diseases.
Journal: Journal of immunology research
Published: July 28, 2023
Interleukins 4 and 21 Protect Anti-IgM Induced Cell Death in Ramos B Cells: Implication for Autoimmune Diseases.
Journal: Frontiers in immunology
Published: April 14, 2022
SM03, an Anti-CD22 Antibody, Converts Cis-to-Trans Ligand Binding of CD22 against α2,6-Linked Sialic Acid Glycans and Immunomodulates Systemic Autoimmune Diseases.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 23, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026